PLAINVILLE, Mass. — Just a year after opening its $180 million viral vector manufacturing site in Massachusetts, Thermo Fisher already has expansion on its mind.
The contract development and manufacturing organization has the ability to “double the production, or even triple the production” at its Plainville site, VP and general manager of viral vector services Cédric Volanti said Tuesday during a media event.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.